Literature DB >> 5579459

Cardiovascular actions of substituted adenosine analogues.

J A Angus, L B Cobbin, R Einstein, M H Maguire.   

Abstract

1. The effects of adenosine on systemic blood pressure, coronary blood flow and cardiac contractility and rate were studied in anaesthetized open-thorax dogs.2. The potency and duration of action of substituted adenosine analogues were compared with that of adenosine.3. With the exception of 2-chloroadenosine, in which coronary dilator activity was enhanced, substitution in the 2-position of the adenosine molecule reduced activity.4. In all cases 2-substitution prolonged the duration of the coronary dilator activity of adenosine.5. N(6)-Methylation of adenosine and 2-chloroadenosine reduced their coronary dilator activities, but had no effect on the duration of the response.6. Comparison of the coronary dilator potencies and hypotensive activities of 2-ethylaminoadenosine and 2-methoxyadenosine indicates that these analogues have some specificity for the coronary bed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5579459      PMCID: PMC1702762          DOI: 10.1111/j.1476-5381.1971.tb07067.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  INFLUENCE OF A PYRIMIDOPYRIMIDINE DERIVATIVE ON DEAMINATION OF ADENOSINE BY BLOOD.

Authors:  R D BUNAG; C R DOUGLAS; S IMAI; R M BERNE
Journal:  Circ Res       Date:  1964-07       Impact factor: 17.367

2.  [The elimination of adenosine from the blood under the influence of 2,6-bis(diethanolamino)-4,8-dipiperidinopyrimido-(5,4-d) pyrimidine and papaverine].

Authors:  F W KOSS; G BEISENHERZ; R MAERKISCH
Journal:  Arzneimittelforschung       Date:  1962-11

3.  Coronary vasodilator properties of purine and pyrimidine derivatives.

Authors:  M M WOLF; R M BERNE
Journal:  Circ Res       Date:  1956-05       Impact factor: 17.367

4.  Enzymatic deamination and vasodepressor effects of adenosine analogs.

Authors:  D A CLARKE; J DAVOLL; F S PHILIPS; G B BROWN
Journal:  J Pharmacol Exp Ther       Date:  1952-11       Impact factor: 4.030

5.  Release of adenosine by the normal myocardium in dogs and its relationship to the regulation of coronary resistance.

Authors:  R Rubio; R M Berne
Journal:  Circ Res       Date:  1969-10       Impact factor: 17.367

6.  The effects of an intracoronary infusion of adenosine on cardiac performance, blood supply and on myocardial metabolism in dogs.

Authors:  G Raberger; O Kraupp; W Stühlinger; G Nell; J J Chirikdjian
Journal:  Pflugers Arch       Date:  1970       Impact factor: 3.657

7.  Release of adenosine in reactive hyperemia of the dog heart.

Authors:  R Rubio; R M Berne; M Katori
Journal:  Am J Physiol       Date:  1969-01

8.  [Dosage-effect relations between coronary blood flow and heart rate for adenosine].

Authors:  H Schöndorf; W Rummel; K Pfleger
Journal:  Experientia       Date:  1969-01-15

9.  [Influence of pyrimidopyrimidine and pteridine derivatives on phosphate and adenosine permeability in human erythrocytes].

Authors:  E Gerlach; B Deuticke; F W Koss
Journal:  Arzneimittelforschung       Date:  1965-05

10.  Studies on adenosine deaminase. I. Purification and properties of ox heart adenosine deaminase.

Authors:  M Rockwell; M H Maguire
Journal:  Mol Pharmacol       Date:  1966-11       Impact factor: 4.436

View more
  2 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

2.  Studies on the coronary dilator actions of some adenosine analogues.

Authors:  L B Cobbin; R Einstein; M H Maguire
Journal:  Br J Pharmacol       Date:  1974-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.